No functional clustering were seen in these 16 new mutations, though they did include known driver genes such as TP53, RB1, PIK3CA, ATR. These results suggest the importance of broadly tracking ctDNA changes using a large gene panel instead of tumor-informed approach that focuses only on select tumor-derived mutations. This evidence concerns the gene TP53 and neoplasm.